Skip to main content

Brain and bone metastasis from malignant thyroid carcinomas originating in western Saudi Arabia

Background

We have previously investigated the frequency of gene mutations in RET and HRAS affecting medullary thyroid carcinomas (MTCs) and gene mutations in BRAF, HRAS, KRAS, and NRAS affecting non-medullary thyroid carcinomas (non-MTCs). Non-MTCs include follicular TCs (FTCs), anaplastic TCs (ATCs), and papillary TCs (PTCs) and its histological variants. In this study we surveyed the frequency of metastasis to the brain or bone in our case series of MTCs and non-MTCs.

Materials and methods

We surveyed histopathological reports from two main hospitals in the Western region of Saudi Arabia for the presence of brain and/or bone metastasis in a case series of malignant TCs comprising 13 MTCs and 238 non-MTCs.

Results

Our survey identified a small number of malignant TCs affected with bone and/or brain metastasis. Out of 115 PTCs, two cases were reported to have a metastasis to the bone and one case had a concurrent metastasis to the brain and to the skull bone. One case with a metastasis to the bone revealed in the mutational screening an uncommon K601E mutation in the BRAF gene whereas a rare insertion in BRAF codon 599 (insT599T) was identified in the case with the metastases to the brain and skull bone. This latter mutation was confined to the tumor. Out of 42 FVPTCs (follicular variants of PTCs), two cases were reported to have a metastasis to the bone. One of the FVPTCs displayed a HRAS Q61K mutation. In addition, one patient presenting with a micro PTC (tumor size ≤1 cm) had a brain metastasis originating from a breast carcinoma.

Conclusions

Our survey reveals that especially, metastases to the brain are infrequent events in malignant TCs which is in concordance with other surveys [1]. The association of rare BRAF mutations with brain and bone metastasis from TC requires further investigations.

This study was supported by King Abdulaziz City for Science and Technology (KACST) grant TK-0961-12.

References

  1. 1.

    McWilliams RR, Giannini C, Hay ID, Atkinson JL, Stafford SL, Buckner JC: Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer. 2003, 98 (2): 356-362.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hans-Juergen Schulten.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Baghallab, I., Ata, M., Hassan, N.A. et al. Brain and bone metastasis from malignant thyroid carcinomas originating in western Saudi Arabia. BMC Genomics 15, P64 (2014). https://0-doi-org.brum.beds.ac.uk/10.1186/1471-2164-15-S2-P64

Download citation

Keywords

  • Bone Metastasis
  • Brain Metastasis
  • Thyroid Carcinoma
  • BRAF Mutation
  • Medullary Thyroid Carcinoma